Cardinal Health 414, Inc.

Form 483 issued February 25, 2020 · Seattle, Washington

Inspection
Feb 18 – Feb 25, 2020
Investigator
Anita Narula
Observations
3
Pages
5
FEI number
3003706047

In short: On February 25, 2020, FDA issued a Form 483 with 3 observations to Cardinal Health 414, Inc. in Seattle, Washington (FEI 3003706047) after an inspection that ran Feb 18 – Feb 25, 2020. The investigator was Anita Narula. The most-cited regulation is 21 CFR 212.20 (what activities must I perform to ensure drug quality?).

What FDA observed

Preview: the opening words of each observation
  1. 01

    Your firm lacks adequate production and process controls to ensure the consistent production of a PET…

  2. 02

    When errors occurred or a production batch or any component of the batch, failed to meet…

  3. 03

    You did not follow…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Cardinal Health 414, Inc.?

FDA listed 3 observations on this Form 483. The most-cited regulation is 21 CFR 212.20 (what activities must I perform to ensure drug quality?). The opening words of each observation are shown on this page.

Who inspected Cardinal Health 414, Inc.?

Anita Narula is named on this Form 483, for the inspection of Feb 18 – Feb 25, 2020. Each investigator has a profile showing what they cite most.

When was Cardinal Health 414, Inc. inspected by FDA?

The inspection ran Feb 18 – Feb 25, 2020, and the Form 483 is dated February 25, 2020.

How do I get the full Form 483 for Cardinal Health 414, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free